Mozessohn, Lee, and Rena Buckstein. 2026. “Should We Move past Erythropoietin-Stimulating Agent Monotherapy in Lower-Risk Myelodysplastic Syndromes?”. Haematologica 111 (2). Pavia, Italy, 451-53. https://doi.org/10.3324/haematol.2025.288157.